|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9660 USD | +4.32% |
|
-0.09% | -67.80% |
| May. 15 | CbdMD, Inc., Q2 2025 Earnings Call, May 15, 2025 | |
| May. 15 | CbdMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025 | CI |
| Capitalization | 8.61M 7.38M 6.88M 6.4M 11.81M 741M 13.19M 83.11M 31.37M 347M 32.28M 31.61M 1.28B | P/E ratio 2025 * |
-0.24x | P/E ratio 2026 * | -1.1x |
|---|---|---|---|---|---|
| Enterprise value | 8.61M 7.38M 6.88M 6.4M 11.81M 741M 13.19M 83.11M 31.37M 347M 32.28M 31.61M 1.28B | EV / Sales 2025 * |
0.42x | EV / Sales 2026 * | 0.38x |
| Free-Float |
59.86% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: cbdMD, Inc.
More press releases
| 1 day | +4.32% | ||
| 1 week | -0.09% | ||
| Current month | +8.32% | ||
| 1 month | +15.27% | ||
| 3 months | -47.50% | ||
| 6 months | -75.97% | ||
| Current year | -67.80% |
| 1 week | 0.89 |  | 1.01 |
| 1 month | 0.82 | | 1.01 |
| Current year | 0.76 | | 6.54 |
| 1 year | 0.76 | | 6.54 |
| 3 years | 0.76 | | 320.4 |
| 5 years | 0.76 | | 2,458.8 |
| 10 years | 0.76 | | 2,606.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
T. Kennedy
CEO | Chief Executive Officer | 45 | 2023-02-28 |
Zeb Booker
CTO | Chief Tech/Sci/R&D Officer | - | 2018-12-31 |
Sibyl Swift
CTO | Chief Tech/Sci/R&D Officer | 44 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Bakari Sellers
BRD | Director/Board Member | 40 | 2017-02-28 |
William Raines
BRD | Director/Board Member | 65 | 2019-04-18 |
Scott Stephen
CHM | Chairman | 59 | 2022-06-02 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.32% | -0.09% | -80.52% | -99.34% | 8.61M | ||
| +1.34% | -2.69% | -9.09% | +139.83% | 693B | ||
| +0.44% | +4.33% | +5.33% | -6.04% | 394B | ||
| -1.12% | -1.66% | +10.59% | +26.54% | 334B | ||
| -2.22% | -5.55% | -53.26% | -1.90% | 287B | ||
| +0.58% | +0.66% | -7.15% | -21.43% | 259B | ||
| -1.12% | -4.09% | -2.94% | +12.40% | 223B | ||
| -0.17% | -1.49% | -15.11% | -7.23% | 215B | ||
| -1.91% | -4.08% | -35.65% | -13.41% | 201B | ||
| -1.17% | -0.17% | -10.94% | +20.88% | 158B | ||
| Average | -0.03% | -1.62% | -19.87% | +5.03% | 276.49B | |
| Weighted average by Cap. | -0.41% | -1.66% | -11.07% | +35.84% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 20.56M 17.64M 16.44M 15.3M 28.22M 1.77B 31.51M 199M 74.97M 830M 77.14M 75.54M 3.05B | 22.62M 19.41M 18.08M 16.83M 31.04M 1.95B 34.66M 218M 82.47M 913M 84.86M 83.1M 3.36B |
| Net income | -2.98M -2.55M -2.38M -2.21M -4.08M -256M -4.56M -28.73M -10.85M -120M -11.16M -10.93M -442M | -1.02M -873K -814K -757K -1.4M -87.67M -1.56M -9.83M -3.71M -41.11M -3.82M -3.74M -151M |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
42
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-18 | 0.9660 $ | +4.32% | 30,796 |
| 25-07-17 | 0.9260 $ | +0.58% | 12,341 |
| 25-07-16 | 0.9207 $ | -4.74% | 19,414 |
| 25-07-15 | 0.9665 $ | +0.68% | 46,028 |
| 25-07-14 | 0.9600 $ | -0.71% | 197,378 |
Delayed Quote Nyse, July 18, 2025 at 04:00 pm EDT
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.9660USD
Average target price
3.000USD
Spread / Average Target
+210.56%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- YCBD Stock
Select your edition
All financial news and data tailored to specific country editions
